Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Rilotumumab Exposure-Response Relationship in Patients With Advanced or Metastatic Gastric Cancer.
Rilotumumab plus ECX demonstrated concentration-dependent effects on OS.
»
02/26/15
Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers.
Expression levels of transcription factors AP-1 and SP-1 correlated with upregulation of GSTP-1 expression in colorectal cancer cells.
»
04/18/14
Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.
Chemosensitization by regorafenib is mediated by enhanced PUMA induction through different pathways.
»
04/24/14
SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT.
SATB1 also promoted cell cycle progression.
»
02/10/15
MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer.
Dual-luciferase reporter assay recognized PDRG1 as direct downstream target gene of miR-214.
»
02/26/15
Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours.
MRE11 protein levels were correlated with NBS1 and RAD50 mRNA.
»
03/15/14
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk.
T allele had a significant high risk of gastric and bladder cancer, but not in other cancers.
»
02/20/15
Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells.
Akt/PHB signaling cascade identified as a novel mechanism of cancer cell proliferation.
»
10/05/14
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
TMPRSS2:ERG fusion was associated with a statistically significant lower risk of prostate cancer mortality.
»
11/07/14
MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
Study confirms down-regulation of MYCBP2 at the mRNA and protein levels.
»
10/08/14
< Prev
Next >